<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02750605</url>
  </required_header>
  <id_info>
    <org_study_id>TF3</org_study_id>
    <nct_id>NCT02750605</nct_id>
  </id_info>
  <brief_title>DEB ( Drug Eluting Balloon) in Crural Arteries and Critical Limb Ischemia</brief_title>
  <official_title>Randomized Trial Comparing Drug Coated Balloon vs Plain Balloon Angioplasty in Critical Limb Ischemia and Treatment of Long Lesions in Crural Arteries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Skane University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Skane University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to compare short- medium long-term results in treatment of PAD
      (peripheral arterial disease) in the crural arteries with either drug coated balloon or
      conventional balloons in a prospective , randomized, single center study

      Results will be defined as:

      Limb salvage, Event-free survival, Freedom from TLR (target lesion revascularization),
      Primary patency, Clinical success, Serious adverse events, and the patients will be
      followed-up for 1 years.

      Primary endpoints:

      Primary Patency at 12 months

      Secondary endpoints:

      Event free survival, Clinical success at 6,12 months, Technical success, Serious adverse
      events, TLR (clinical driven),
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 2016</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary patency of treated crural vessels</measure>
    <time_frame>12 months</time_frame>
    <description>Evaluation with MRA (Magnetic Resonans Angiography) at 12 months, regarding binary restenosis or occlusion in the treated arterial segment. Proportion of treated segments that remains open.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical driven target lesion revascularization (TLR)</measure>
    <time_frame>12 months</time_frame>
    <description>Porportion of patients that needs retreatment in in the monitored arterial segment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Peripheral Vascular Diseases</condition>
  <arm_group>
    <arm_group_label>Drug eluting balloon angioplasty</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention with DEB angioplasty in long lesions of crural arteries</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Plain old balloon angioplasty</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention with plain old balloon angioplasty POBA in long lesions of crural arteries</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DEB</intervention_name>
    <description>Intervention with drug eluting balloon.</description>
    <arm_group_label>Drug eluting balloon angioplasty</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>POBA</intervention_name>
    <description>Intervention with old technology as comparison</description>
    <arm_group_label>Plain old balloon angioplasty</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Critical limb ischemia. Rutherford class 4-6

          -  Crural disease, long lesions, more than 2 cm.

          -  Life expectancy &gt; 1year

          -  &gt; 18 years

        Exclusion Criteria:

          -  Pregnancy

          -  Patients disapproval

          -  Allergy to drug or contrast
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Torbjörn Fransson</last_name>
    <role>Principal Investigator</role>
    <affiliation>SUS, Malmö</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Torbjörn Fransson</last_name>
    <phone>+4640338691</phone>
    <email>torbjorn.fransson@skane.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Vascular center</name>
      <address>
        <city>Malmö</city>
        <zip>23594</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Torbjörn Fransson</last_name>
      <phone>+4640338691</phone>
      <email>torbjorn.fransson@skane.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 19, 2016</study_first_submitted>
  <study_first_submitted_qc>April 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 25, 2016</study_first_posted>
  <last_update_submitted>May 28, 2017</last_update_submitted>
  <last_update_submitted_qc>May 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Skane University Hospital</investigator_affiliation>
    <investigator_full_name>Torbjorn Fransson</investigator_full_name>
    <investigator_title>Consultant, Vascular Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

